Using data from the ImproveCareNow Registry (ICN2), this collaborative study will examine the effectiveness of adalimumab in the treatment of pediatric Crohn's disease. Funded by AbbVie.
Using data from the ImproveCareNow Registry (ICN2), this collaborative study will examine the effectiveness of adalimumab in the treatment of pediatric Crohn's disease. Funded by AbbVie.
Built by Veracity Media on NationBuilder